Tobacco Treatment in the Context of Lung Cancer Screening
The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.
Checked against the public recordLast updated Nov 22, 2024 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Treatment
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Medical University of South Carolina
- Interventions being studied
- Behavioral: Text messaging plus nicotine replacement therapy; Other: Standard Care at Lung Cancer Screening
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion: 1. 55 years or older 2. 30 pack year history of smoking 3. current smoker (defined as breath carbon monoxide\>6ppm) 4. willing to be randomized 5. English speaking Exclusion: 1. unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, severe alcohol dependence, substance abuse, or dementia 2. in the immediate (within 2 weeks) post myocardial infarction period 3. serious arrhythmias 4. unstable angina pectoris 5. hemodynamically or electrically unstable 6. currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking NRT or other cessation medications, enrolled in the Quitline, in another drug study).
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Medical University of South CarolinaCharleston, South Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 22, 2024. Always confirm current availability with the study team.